GH1 and polycystic ovary syndrome: Since GH is involved in the regulation of reproductive functions, it has been used as a therapeutic option in ART for more than 30 years, especially in poor ovarian responders (PORs) [16,17,18,19,20,21], polycystic ovary syndrome (PCOS) [22,23], and poor embryonic development [24,25].